News | August 12, 2022
GL Chemtech partners with Edgewater Capital to accelerate growth
Investment in response to increased demand for North American-based chemistry services
Investment in response to increased demand for North American-based chemistry services
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
U GRO Capital is a listed MSME lending fintech platform
The fund will take equity positions in India-focused healthcare and life sciences-related companies
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Transition to a fermentation-based globally integrated CDMO platform
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Access to genomic testing, not therapy cost, is the biggest challenge
Ex-US revenue rose sharply by 21% YoY to Rs. 2, 240.4 crore ($254 million); Operational PAT grew 50.3% YoY to Rs. 518.1 crore
Subscribe To Our Newsletter & Stay Updated
